ProLabs Launches USDA-Approved LTCI To Aid In Treatment Of FeLV And FIV
Veterinarians and Cat Owners Get Help in Treating Killer Diseases. Feline leukemia virus (FeLV) and Feline Immunodeficiency virus (FIV) are the most common life-threatening infectious diseases of cats. Until LTCI's introduction, there was no approved treatment for these widespread, incurable viruses that, like HIV/AIDS in people, suppress the immune system.
About 3% of all US cats are infected with FeLV, and a similar number suffer with FIV. These rates are dramatically higher in stray cats and house cats that go outside.
As news of the availability of LTCI's (Lymphocyte T-Cell Immunomodulator) groundbreaking technology spread, excited cat owners were buzzing about it well before most veterinarians had an opportunity to read about it in their professional journals.
"As soon as we announced the launch of LTCI, concerned pet owners and hopeful veterinarians -- who have been looking for a treatment for FeLV-FIV for decades -- have been calling and e-mailing with questions about how LTCI works and where to get it," reports Brian Reardon, Brand Manager for ProLabs, Ltd., the marketers of LTCI. "It's a great product to talk about: It's safe, and as the only FeLV/FIV treatment that has ever been granted a conditional license by the USDA, ProLabs is in a very enviable position within the pet animal health world."
Until LTCI became available, veterinarians who diagnosed feline patients with FeLV and/or FIV had no approved treatment for these disorders. "LTCI provides veterinarians with an approved treatment option beyond anything previously possible. Telling clients that 'there is nothing to be done' for their cat should no longer be in a practitioner's lexicon when it comes to treating cats with FeLV/FIV," commented ProLabs Technical Services Manager, Dr. Joel Ehrenzweig, at a recent meeting of the American Association of Feline Practitioners.
Source
ProLabs and Tradewinds, divisions of AgriLabs, Ltd.
About 3% of all US cats are infected with FeLV, and a similar number suffer with FIV. These rates are dramatically higher in stray cats and house cats that go outside.
As news of the availability of LTCI's (Lymphocyte T-Cell Immunomodulator) groundbreaking technology spread, excited cat owners were buzzing about it well before most veterinarians had an opportunity to read about it in their professional journals.
"As soon as we announced the launch of LTCI, concerned pet owners and hopeful veterinarians -- who have been looking for a treatment for FeLV-FIV for decades -- have been calling and e-mailing with questions about how LTCI works and where to get it," reports Brian Reardon, Brand Manager for ProLabs, Ltd., the marketers of LTCI. "It's a great product to talk about: It's safe, and as the only FeLV/FIV treatment that has ever been granted a conditional license by the USDA, ProLabs is in a very enviable position within the pet animal health world."
Until LTCI became available, veterinarians who diagnosed feline patients with FeLV and/or FIV had no approved treatment for these disorders. "LTCI provides veterinarians with an approved treatment option beyond anything previously possible. Telling clients that 'there is nothing to be done' for their cat should no longer be in a practitioner's lexicon when it comes to treating cats with FeLV/FIV," commented ProLabs Technical Services Manager, Dr. Joel Ehrenzweig, at a recent meeting of the American Association of Feline Practitioners.
Source
ProLabs and Tradewinds, divisions of AgriLabs, Ltd.
posted by Dr. Holman @ 10:30 AM
0 Comments:
Post a Comment
Thanks for your comment - we love hearing from our readers!
Subscribe to Post Comments [Atom]
<< Home